PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.

Revenue
+11.5%
EPS
+16.4%
Free cash flow
−4.31%
Total debt
+7.48%

Quarter to September 2026, against a year earlier

49.10 1.10 −2.19%
Market cap
$8.0B
P/E
28.6×
Fwd P/E
21.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a

PACS Group, Inc. (PACS) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, PACS Group, Inc. (PACS) trades at a P/B ratio of 6.5×. Over the past ten years it has ranged from 1.5× (September 2025) to 29.4× (June 2024); the current reading is higher than 73% of that period. That is above the Medical Care Facilities industry median of 3.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.3× 134.31%
FY2024 2.7× (87.88%)
FY2023 22.2× 0.00%
FY2022 22.2× 0.00%
FY2021 22.2× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 5.4× (10.67%)
Jun 2026 6.0× 24.86%
Mar 2026 4.8× (23.10%)
Dec 2025 6.3× 156.79%
11 more quarters

Against its own ten years

Low 1.5× High 29.4×
Ten-year median 5.6×
Current reading's percentile 73

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on PACS